Long-term studies on carcinogenicity and promoting effect of phenylbutazone in DONRYU rats. 1987

A Meakawa, and H Onodera, and H Tanigawa, and K Furuta, and J Kanno, and C Matsuoka, and T Ogiu, and Y Hayashi

The carcinogenicity and promoting effect of phenylbutazone were investigated in inbred DONRYU rats. In the carcinogenicity study, both sexes were administered the chemical at dietary levels of 0 (control), 0.125, or 0.25% for 2 years. Toxic lesions were associated with phenylbutazone treatment in the kidney and digestive tract, appearing to have an adverse effect on life expectancy. Various tumors were detected in all groups including the controls. With the exception of pheochromocytoma in the female high-dose group, no statistically significant increase in yield of any tumors, including leukemia, was apparent in the treated groups of either sex when the data were analyzed by Fisher's exact probability and/or chi-square tests. Application of an age-adjusted statistical analysis revealed a slight positive effect regarding the occurrence of pheochromocytomas, neoplastic liver nodules, and leukemias in females. However, these tumors are commonly observed to develop spontaneously in this rat strain, and no such effect was apparent in the male groups. In addition, no differences in incidences of relevant preneoplastic lesions were evident between control and treated groups. Thus phenylbutazone showed no carcinogenic activity in DONRYU rats when given continuously in the diet for 2 years. For the investigation of promoting effect, phenylbutazone was given as a dietary supplement for 2 years subsequent to initiation with N-ethyl-N-nitrosourea or N-propyl-N-nitrosourea. No enhancement of nitrosourea-induced leukemogenesis was apparent, although a slight promoting effect was demonstrated for renal and thyroid tumorigenesis.

UI MeSH Term Description Entries
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D008114 Liver Neoplasms, Experimental Experimentally induced tumors of the LIVER. Hepatoma, Experimental,Hepatoma, Morris,Hepatoma, Novikoff,Experimental Hepatoma,Experimental Hepatomas,Experimental Liver Neoplasms,Hepatomas, Experimental,Neoplasms, Experimental Liver,Experimental Liver Neoplasm,Liver Neoplasm, Experimental,Morris Hepatoma,Novikoff Hepatoma
D008297 Male Males
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D009607 Nitrosourea Compounds A class of compounds in which the core molecule is R-NO, where R is UREA. Compounds, Nitrosourea
D010653 Phenylbutazone A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS. Diphenylbutazone,Fenilbutazon,Butacote,Butadion,Butadione,Butapirazol,Butapyrazole,Butazolidin
D010673 Pheochromocytoma A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298) Pheochromocytoma, Extra-Adrenal,Extra-Adrenal Pheochromocytoma,Extra-Adrenal Pheochromocytomas,Pheochromocytoma, Extra Adrenal,Pheochromocytomas,Pheochromocytomas, Extra-Adrenal
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005038 Ethylnitrosourea A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties. Nitrosoethylurea,N-Ethyl-N-nitrosourea,N Ethyl N nitrosourea

Related Publications

A Meakawa, and H Onodera, and H Tanigawa, and K Furuta, and J Kanno, and C Matsuoka, and T Ogiu, and Y Hayashi
December 1997, Annals of the New York Academy of Sciences,
A Meakawa, and H Onodera, and H Tanigawa, and K Furuta, and J Kanno, and C Matsuoka, and T Ogiu, and Y Hayashi
December 2002, Annals of the New York Academy of Sciences,
A Meakawa, and H Onodera, and H Tanigawa, and K Furuta, and J Kanno, and C Matsuoka, and T Ogiu, and Y Hayashi
June 2016, Journal of applied toxicology : JAT,
A Meakawa, and H Onodera, and H Tanigawa, and K Furuta, and J Kanno, and C Matsuoka, and T Ogiu, and Y Hayashi
October 1987, Cancer letters,
A Meakawa, and H Onodera, and H Tanigawa, and K Furuta, and J Kanno, and C Matsuoka, and T Ogiu, and Y Hayashi
August 1983, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
A Meakawa, and H Onodera, and H Tanigawa, and K Furuta, and J Kanno, and C Matsuoka, and T Ogiu, and Y Hayashi
February 1979, Food and cosmetics toxicology,
A Meakawa, and H Onodera, and H Tanigawa, and K Furuta, and J Kanno, and C Matsuoka, and T Ogiu, and Y Hayashi
December 2002, Annals of the New York Academy of Sciences,
A Meakawa, and H Onodera, and H Tanigawa, and K Furuta, and J Kanno, and C Matsuoka, and T Ogiu, and Y Hayashi
December 2002, Annals of the New York Academy of Sciences,
A Meakawa, and H Onodera, and H Tanigawa, and K Furuta, and J Kanno, and C Matsuoka, and T Ogiu, and Y Hayashi
October 1986, Journal of the National Cancer Institute,
A Meakawa, and H Onodera, and H Tanigawa, and K Furuta, and J Kanno, and C Matsuoka, and T Ogiu, and Y Hayashi
July 1989, International journal of pancreatology : official journal of the International Association of Pancreatology,
Copied contents to your clipboard!